# Vitamin D3 in Systemic Lupus Erythematosus

> **NCT00710021** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 57 (actual)

## Conditions studied

- Systemic Lupus Erythematosus
- SLE
- Lupus

## Interventions

- **DRUG:** Vitamin D3
- **DRUG:** Vitamin D3 placebo

## Key facts

- **NCT ID:** NCT00710021
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2017-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00710021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00710021, "Vitamin D3 in Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00710021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*